Evidence map›Paper›PMID 31137655›Full record

SynthesisNutrients2019

Green Tea Intake and Risks for Dementia, Alzheimer's Disease, Mild Cognitive Impairment, and Cognitive Impairment: A Systematic Review.

Saki Kakutani, Hiroshi Watanabe, Norihito Murayama

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 4 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 4 syntheses or guidelines pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Saki KakutaniResearch Institute, Suntory Global Innovation Center Limited, Suntory World Research Center, 8-1-1 Seikadai, Seika-cho, Souraku-gun, Kyoto 619-0284, Japan. Saki_Kakutani@suntory.co.jp.
Hiroshi WatanabeResearch Institute, Suntory Global Innovation Center Limited, Suntory World Research Center, 8-1-1 Seikadai, Seika-cho, Souraku-gun, Kyoto 619-0284, Japan. H_Watanabe@suntory.co.jp.
Norihito MurayamaResearch Institute, Suntory Global Innovation Center Limited, Suntory World Research Center, 8-1-1 Seikadai, Seika-cho, Souraku-gun, Kyoto 619-0284, Japan. Norihito_Murayama@suntory.co.jp.
Suntory (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dementia has become a major issue that requires urgent measures. The prevention of dementia may be influenced by dietary factors. We focused on green tea and performed a systematic review of observational studies that examined the association between green tea intake and dementia, Alzheimer's disease, mild cognitive impairment, or cognitive impairment. We searched for articles registered up to 23 August 2018, in the PubMed database and then for references of original articles or reviews that examined tea and cognition. Subsequently, the extracted articles were examined regarding whether they included original data assessing an association of green tea intake and dementia, Alzheimer's disease, mild cognitive impairment, or cognitive impairment. Finally, we included three cohort studies and five cross-sectional studies. One cohort study and three cross-sectional studies supported the positive effects of green tea intake. One cohort study and one cross-sectional study reported partial positive effects. The remaining one cohort study and one cross-sectional study showed no significant association of green tea intake. These results seem to support the hypothesis that green tea intake might reduce the risk for dementia, Alzheimer's disease, mild cognitive impairment, or cognitive impairment. Further results from well-designed and well-conducted cohort studies are required to derive robust evidence.

Indexed as

Camellia sinensisCognitionTeaAdultAgedAge FactorsAlzheimer DiseaseCognitive AgingCognitive DysfunctionFemaleHumansMaleMiddle AgedObservational Studies as TopicProtective FactorsRisk AssessmentTeaAlzheimer’s diseasebeveragecognitive impairmentdementiaelderlyfree-living populationsgreen tea intakemild cognitive impairmentobservational studiessystematic review

Identifiers

PMID31137655
PMCPMC6567241
OpenAlexW2944878260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.